Community Webinar: Topline Data from EXPLORE44® Clinical Trial

Tune in on the first of May to hear from the team at Avidity Biosciences on topline data from their EXPLORE44® clinical trial, which is assessing the safety and efficacy of the investigational therapy delpacibart zotadirsen (formerly AOC 1044, abbreviated as del-zota) in people living with Duchenne muscular dystrophy mutations amenable to exon 44 skipping […]

Clinical Impact of FORCETM Platform in Duchenne

Please join us during our Community Webinar Series on April 17th as we welcome the team from Dyne Therapeutics to speak on updates to the DELIVER trial of DYNE-251 in males with Duchenne mutations amenable to exon 51 skipping. Clinical Impact of FORCETM Platform in Duchenne April 17, 2025 | 1pm ET| Zoom

Community Webinar: Cardiac Devices

Tune in to hear from Andreas Barth on cardiac devices in Duchenne, Becker, and Carrier patients with an emphasis on implanted devices.